DCAF6 and amyotrophic lateral sclerosis: In our study, we utilized AAV-NRIP (AAV DJ/8 serotype) as a gene therapy drug to induce NRIP expression in ALS-SOD1G93A mice through intramuscular injection to assess therapeutic efficacy.